Advances in Cancer Research

Advances in Cancer Research, Volume 138, the latest release in this ongoing, well-regarded serial provides invaluable information on the exciting and fast-moving field of cancer research. This volume presents original reviews on research bridging oncology and gene expression, with this volume covering unconventional approaches to modulating the immunogenicity of tumor cells, tumor dormancy and immunoediting, the emerging role of anti-apoptotic Bcl-2 family proteins in chemoresistance, Beclin-1 and autophagy, MDA-7/IL-24, and nanotechnology and medicine.

1. Leveraging Epigenetics to Enhance the Cellular Response to Chemotherapies and Improve Tumor ImmunogenicityLiliya Tyutyunyk-Massey, Syed Haqqani, Reshma Mandava, Kirubel Kentiba, Mallika Dammalapati, Nga Dao, Joshua Haueis, David Gewirtz and Joseph W. Landry2. VDAC Regulation: A Mitochondrial Target to Stop Cell ProliferationDiana Fang and Eduardo N. Maldonado3. Acquired Resistance to Drugs Targeting Tyrosine KinasesSteven A. Rosenzweig4. Extracellular Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological OutcomesScott T. Eblen5. Role of MDA-7/IL-24 a Multifunction Protein in Human DiseasesMitchell E. Menezes, Praveen Bhoopathi, Anjan K. Pradhan, Luni Emdad, Swadesh K. Das, Chunqing Guo, Xiang-Yang Wang, Devanand Sarkar and Paul B. Fisher6. Advances and Challenges of HDAC Inhibitors in Cancer TherapeuticsJesse J. McClure, Xiaoyang Li and C. James Chou7. Prospects of Gene Therapy to Treat MelanomaMitchell E. Menezes, Sarmistha Talukdar, Stephen L. Wechman, Swadesh K. Das, Luni Emdad, Devanand Sarkar and Paul B. Fisher

Researchers and students in the basic and clinical sciences of cancer biology and oncology, plus related areas in genetics, immunology, pharmacology, cell biology, and molecular biology.

• Provides information on cancer research
• Offers outstanding and original reviews on a range of cancer research topics
• Serves as an indispensable reference for researchers and students alike